Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation (Q44104453)

29 November 2017

title

Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation (English)

1 reference

29 November 2017

0 references

K Kimura

1

1 reference

29 November 2017

E P Gelmann

series ordinal

2

1 reference

29 November 2017

publication date

1 September 2002

1 reference

Cell Death & Differentiation

29 November 2017

published in

1 reference

29 November 2017

volume

9

1 reference

29 November 2017

issue

9

1 reference

29 November 2017

page(s)

972-980

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401049

29 November 2017

exact match

0 references

cites work

Apoptosis and cancer: strategies for integrating programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Tumor necrosis factor receptor and Fas signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

RAIDD is a new 'death' adaptor molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Irreversible inhibition of trypsin by TLCK. A continuous method for kinetic study of irreversible enzymatic inhibitors in the presence of substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Interleukin-1 beta induced activation of NF-kappa B in insulin producing RINm5F cells is prevented by the protease inhibitor N alpha-p-tosyl-L-lysine chloromethylketone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

NF-kappaB to the rescue: RELs, apoptosis and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Cathepsin D targeted by acid sphingomyelinase-derived ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

Tumor cell survival and resistance to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Synthesis of procaspases-3 and -7 during apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Identification of the histidine residue at the active center of trypsin labelled by TLCK

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401049

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401049

1 reference

29 November 2017

1 reference